ArticleCurrent oncology (Toronto, Ont.)2022

Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis.

Kimberly Guinan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.